| CECIL |
| TEXT BOOK of MEDICINE |
Section XI Renal and Genitourinary Diseases
130 BENIGN PROSTATE DISEASE AND PROSTATITIS
Michael J. Barry • Mary McNaughton-Collins • |
REFERENCES
- Djavan B, Chapple C, Milani S, Marberger M: State of the art on the efficacy and tolerability of alpha-1 adrenoreceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Urology 2004;64:1081–1088.
- McConnell JD, Roehrborn CG, Bautista OM, et al: The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med 2003;349:2385–2396.
- Roehrborn CG, Boyle P, Nichol JC, et al: Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia. Urology 2002;60:434–441.
- Thompson IM, Goodman PJ, Tangen CM, et al: The influence of finasteride on the development of prostate cancer. N Engl J Med 2003;349:215–224.
- Lepor H, Williford WO, Barry MJ, et al: The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. N Engl J Med 1996;335:533–539.
- Wasson JH, Reda DJ, Bruskewitz RC, et al: A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. N Engl J Med 1995;332:75–79.
- Alexander RB, Propert KJ, Schaeffer AJ, et al: Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: A randomized, double-blind trial. Ann Intern Med 2004;141:581–589.
- Nickel JC, Downey J, Clark J, et al: Levofloxacin for chronic prostatitis/chronic pelvic pain syndrome in men: A randomized placebo-controlled multicenter trial. Urology 2003;62:614–617.
- Cheah PY, Liong ML, Yuen KH, et al: Terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome: A randomized, placebo-controlled trial. J Urol 2003;169:592–596.
- Mehik A, Alas P, Nickel JC, et al: Alfuzosin treatment for chronic prostatitis/chronic pelvic pain syndrome: A prospective, randomized, double-blind, placebo-controlled, pilot study. Urology 2003;62:425–429.
- Nickel JC, Downey J, Pontari MA, et al: A randomized placebo-controlled multicenter study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category IIIA chronic nonbacterial prostatitis). BJU Int 2004;93:991–995.
- Nickel JC, Forrest J, Tomera KM, et al: Effects of pentosan polysulfate sodium in men with chronic pelvic pain syndrome: A multi-center, randomized, placebo-controlled study. J Urol 2005;173:1252–1255.
- McVary KT, Roehrborn CG, Kaminetsky JC, et al: Tadalafil relieves lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol 2007;177:1401–1407.
- Rowe E, Smith C, Laverick L, et al: A prospective, randomized, placebo-controlled, double-blind study of pelvic electromagnetic therapy for the treatment of chronic pelvic pain syndrome with 1 year of follow-up. J Urol 2005;173:2044–2047.
